Second anticancer CAR T therapy receives FDA approval

被引：11

|

作者：

Mullard, Asher

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2017年 / 16卷 / 12期

关键词：

D O I：

10.1038/nrd.2017.249

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

收藏

页码：818 / 818

页数：1

相关论文

共 50 条

[1] Second anticancer CAR T therapy receives FDA approval
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 818 - 818
[2] Efavirenz receives FDA approval
Dobkin, JF
INFECTIONS IN MEDICINE, 1998, 15 (11) : 747 - 747
[3] Zelboraf Receives FDA Approval
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (10) : 1215 - 1215
[4] FDA Approves second CAR T-cell Therapy
Calmes-Miller, Jordan
CANCER DISCOVERY, 2018, 8 (01) : 5 - 6
[5] GELLAN GUM RECEIVES FDA APPROVAL
不详
FOOD TECHNOLOGY, 1990, 44 (11) : 88 - 90
[6] BTG RECEIVES FDA APPROVAL FOR HGH
不详
EUROPEAN CHEMICAL NEWS, 1995, 63 (1670): : 29 - 29
[7] Nivolumab Receives Expanded FDA Approval
Schuyler, Devon
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 738 - 738
[8] Liposuction laser receives FDA approval
不详
EXPERT REVIEW OF MEDICAL DEVICES, 2005, 2 (02) : 136 - 136
[9] Insulin glulisine receives FDA approval
Holt, RIG
DIABETES OBESITY & METABOLISM, 2004, 6 (05): : 397 - 397
[10] HUMAN INSULIN RECEIVES FDA APPROVAL
不详
CLINICAL PEDIATRICS, 1983, 22 (05) : 367 - 367

← 1 2 3 4 5 →